NicOx Presents Preclinical Results at AHA From Antihypertensive Collaboration With Merck &., Inc.
14th Nov 2006, 16:24 GMT
. www.nicox.com NicOx SA announced that very good preclinical results on a prototype compound from its ongoing research collaboration with Merck &., Inc.
NicOx Presents Preclinical Results at AHA From Antihypertensive Collaboration With Merck &., Inc. related news:
- NicOx presents preclinical results at AHA from antihypertensive collaboration with Merck & Co., Inc. — ArriveNet : Health
- NICOX: NicOx presents preclinical results at AHA from antihypertensive collaboration with Merck & Co., Inc. — Market Wire - Medical and Healthcare
- NicOx, Merck produce effective blood pressure results — Pharmaceutical Business Review Latest News
- Merck: New pain killer safer than Vioxx — Business and financial news - CNNMoney.com
- Merck says new drug is safer than Vioxx — Cardiology News from StratCenter.com
- Tests of new Merck painkiller criticized — baltimoresun.com - health & science
- EntreMed Sees Positive Study Results — Operations-Related News from StratCenter.com
- Docs Give Merck Painkiller Acroxia Mixed Reviews — FOXNews.com
- Results Mixed on Merck's New Painkiller — LancasterOnline - Health
- Results mixed on Merck's new painkiller (AP) — Yahoo! News: Health News
Latest news from Partnerships/ Joint Ventures News from StratCenter.com:
- Local firm forms foundation for women's sexual health
- Lifeline Therapeutics to Recognize Previously Deferred Retail Chain Revenue
- Interim Data on Use of tgAAC94 in the Treatment of Inflammatory Arthritis Presented at the American College of Rheumatology Meeting
- NextGen Healthcare and Primetime Medical Software Partner to Enhance Communications Between Doctors and Patients
- 3 Keane Executives to Present at the 2006 Gartner Healthcare Summit in San Diego
- Yaupon Therapeutics Closes $4 mln Financing
- CareTech Solutions and Yampa Valley Med Cntr Announce New IT Outsourcing Agreement
- Genelabs Technologies Reports Financial Results for Q3 and 1st 9 Months of 2006
- Frost & Sullivan Honors Covance for Superior Market Leadership, Creating Enhanced Customer Value in the North American CRO Market
- Health Care Property Closes $1B Offering